Dupixent is indicated for the approximately 300,000 adults in the US with inadequately controlled COPD and an eosinophilic phenotype
At 24 months, data from the Phase 1 exPDite trial continue to show a favorable safety profile in all 12 participants in the trial’s high and low dose cohorts
Pfizer's decision is based on the totality of clinical data
This initiative aims to raise awareness about the importance of monitoring blood sugar levels before indulging in sweets
She reiterated the nation's commitment to eliminating TB as a public health problem by 2030 and ensuring a healthier future for all
These clinical studies support the interchangeability of adalimumab-fkjp at low-concentration with high-concentration adalimumab and ustekinumab biosimilarity
The objectives of the campaign are to raise awareness about glaucoma, its risk factors, and the importance of regular eye check-up
Tremelimumab (Imjudo) in combination with Durvalumab (Imfinzi) is indicated for the treatment of patients with unresectable hepatocellular carcinoma
MVA-BN approved for use against mpox and smallpox in adolescents 12-17 years of age after expedited review with EMA
Palivizumab (Synagis) is indicated for the prevention of serious lower respiratory tract disease requiring hospitalization caused by RSV in children at high risk for RSV disease
Subscribe To Our Newsletter & Stay Updated
